戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  GPCR subgroups (e.g., the ancestral gastrin/cholecystokinin receptor).
2 ily A G protein-coupled receptor, the type 1 cholecystokinin receptor.
3  new molecular model of the agonist-occupied cholecystokinin receptor.
4 antagonist and agonist ligands of the type A cholecystokinin receptor.
5 alpha13 downstream of gastrin and the type 2 cholecystokinin receptor.
6 l sequencing of labeled wild-type and mutant cholecystokinin receptors.
7 udied in solution and docked at type A and B cholecystokinin receptors.
8 iod, inducible/reversible forebrain-specific cholecystokinin receptor-2 transgenic (IF-CCKR-2 tg) mic
9 r 1 (NTSR1), neuropeptide S receptor (NPSR), cholecystokinin receptor A (CCKAR), and the kappa-opioid
10     Similarly, peptides mimicking the TMs of cholecystokinin receptor A, were found to abolish ligand
11 tely 20% of GFP-positive neurons coexpressed cholecystokinin receptor A.
12 n-releasing peptide and carbachol but not to cholecystokinin-receptor agonists.
13 emonstrate that antagonist occupation of the cholecystokinin receptor also results in receptor intern
14                   Two physical models of the cholecystokinin receptor and ligand binding have been pr
15  mass and protein content was independent of cholecystokinin receptors, associated with a rapid incre
16 l hypothalamic nucleus (VMN), we studied the cholecystokinin receptor B-expressing (CCKBR-expressing)
17 e were built into two homology models of the cholecystokinin receptor, based on the recent crystal st
18                   Although both type A and B cholecystokinin receptors bind cholecystokinin with high
19 red Ca2+ signaling with up-regulation of the cholecystokinin receptor but minimal effect upon express
20 titative autoradiography was used to analyze cholecystokinin receptor (CCK-R) binding in the ventrome
21                                       Type 1 cholecystokinin receptor (CCK1R) agonist actions are aff
22                                   The type 1 cholecystokinin receptor (CCK1R) has multiple physiologi
23 f a new antagonist radioligand of the type 1 cholecystokinin receptor (CCK1R), (2-fluorophenyl)-2,3-d
24 lity of cholecystokinin to act at the type 1 cholecystokinin receptor (CCK1R), with elevated levels o
25 rminants for this pocket within type 1 and 2 cholecystokinin receptors (CCK1R and CCK2R), we prepared
26  an analogous motif is present in the type 2 cholecystokinin receptor (CCK2R) with no functional impa
27 urable binding to the closely related type 2 cholecystokinin receptor (CCK2R).
28 eurons directly affect FSH cells through the cholecystokinin receptor, Cck2rb, thereby increasing the
29 ssessment of sites of phosphorylation of the cholecystokinin receptor (CCKR) in its native milieu in
30  neuromuscular junction activity through the cholecystokinin receptor homolog on motor axons, setting
31  within the second extracellular loop of the cholecystokinin receptor interacts with a specific acidi
32 ndependent risk factor for gallstone disease.Cholecystokinin receptors may be responsible for the alt
33 ative pain-facilitating neurons, or block of cholecystokinin receptors prevented or significantly att
34 ype animals and mice lacking the other known cholecystokinin receptor subtype, cholecystokinin-B/gast
35 rotein-coupled receptors, such as the type 1 cholecystokinin receptor, that are targets for drugs in
36 surface and within the helical bundle of the cholecystokinin receptor to the amino terminus of a full
37         A chimeric protein consisting of the cholecystokinin receptor type A (CCKAR) and the green fl
38 , the position 33 probe docked at the type A cholecystokinin receptor was more easily quenched in the
39  whereas the same probe docked at the type B cholecystokinin receptor was more easily quenched in the